DQHK(SZ:000985) Zheng Quan Shi Bao·2025-09-16 13:06Group 1 - The company held a performance briefing on September 16, 2025, to discuss its operating results and financial indicators for the first half of 2025 [1] - Daqing Huake primarily engages in the production and sales of petrochemical products, including C9 and C5 series resins and polypropylene powder, with applications in various industrial sectors [1] - In the first half of 2025, the company achieved operating revenue of 959 million yuan, a year-on-year decrease of 0.85%, and a net profit of 9.064 million yuan, a year-on-year increase of 12.99% [1] Group 2 - The company utilizes by-products from ethylene cracking, such as C5 and propylene, for downstream processing, focusing on enhancing and extending its industrial chain [2] - In 2024, the company invested in a 10,800-ton/year butadiene extraction facility, which has been put into operation, and in 2025, it expanded its isoprene hydrogenation facility to 35,000 tons/year [2] - The company aims to strengthen its core competitiveness by collaborating with research institutions and industry leaders, promoting a new model of "industry-university-research-application" cooperation [2] Group 3 - The company previously announced the unsuccessful public listing of its pharmaceutical division's machinery assets, initially priced at 11.8351 million yuan, which was later reduced to 10.6516 million yuan without finding a buyer [3] - The company will continue to seek potential buyers for the assets of its pharmaceutical division following two unsuccessful attempts at public transfer [3]